| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |